AbbVie | ABBV - PE Price to Earnings

Stock Price
198.71
Daily Change
-2.24 -1.11%
Monthly
-4.09%
Yearly
6.80%
Q2 Forecast
194.46

AbbVie reported 24.03 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
AbbVie 24.03 86.23 Dec/2025
Abbott 24.94 5.78 Mar/2026
ALKERMES 19.54 4.64 Dec/2025
Amgen 25.31 15.82 Dec/2025
AstraZeneca 27.29 5.8 Dec/2025
Biogen 14.02 4.63 Dec/2025
BioMarin Pharmaceutical 19.24 0.21 Dec/2025
Bristol-Myers Squibb 9.28 1.04 Dec/2025
Eisai 26.63 0.46 Dec/2025
Eli Lilly 40.21 9.66 Dec/2025
Gilead Sciences 15.63 0.08 Dec/2025
GlaxoSmithKline 11.15 0.29 Dec/2025
J&J 24.53 0.91 Mar/2026
Medtronic 22.76 1.32 Dec/2025
Merck 13.92 5.08 Dec/2025
Neurocrine Biosciences 835.47 802.2 Dec/2025
Novartis 17.85 2.11 Dec/2025
Pacira 52.68 23.44 Dec/2025
Perrigo 58.96 24.65 Dec/2025
Pfizer 14.48 5.18 Dec/2025
Regeneron Pharmaceuticals 18.11 2.91 Dec/2025
Roche Holding 16.09 3.51 Dec/2025
Sanofi 11.84 0.14 Mar/2026
UCB 29.7 5.52 Dec/2025
United Therapeutics 17.32 1.62 Dec/2025
Vertex Pharmaceuticals 26.15 2.22 Dec/2025
Zoetis 20.42 2.84 Dec/2025